CombiMatrix to Present at the ROTH Conference
March 09 2016 - 5:00AM
CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics
company specializing in DNA-based testing services for prenatal and
postnatal developmental disorders and pre-implantation genetic
screening services, announces that President and Chief Executive
Officer Mark McDonough will present a company overview at the 28th
Annual ROTH Conference on Wednesday, March 16, 2016, at 10:00 a.m.
Pacific time (1:00 p.m. Eastern time). The conference is
being held at The Ritz-Carlton, Laguna Niguel in Dana Point, Calif.
A live webcast of the presentation will be
available on the company’s website at
http://investor.combimatrix.com/events.cfm and will be archived for
30 days.
About CombiMatrix
Corporation
CombiMatrix Corporation provides valuable
molecular diagnostic solutions and comprehensive clinical support
to foster the highest quality in patient care. CombiMatrix
specializes in prenatal diagnostics, miscarriage analysis for
recurrent pregnancy loss, pediatric genetics and pre-implantation
genetic screening, offering DNA-based testing for the detection of
genetic abnormalities beyond what can be identified through
traditional methodologies. CombiMatrix performs genetic testing
utilizing a variety of advanced cytogenomic techniques, including
chromosomal microarray, standardized and customized fluorescence in
situ hybridization (FISH) and high-resolution karyotyping.
CombiMatrix is dedicated to providing high-level clinical support
for healthcare professionals in order to help them incorporate the
results of complex genetic testing into patient-centered medical
decision making. Additional information about CombiMatrix is
available at www.combimatrix.com or by calling (800) 710-0624.
Company Contact: Mark McDonoughPresident & CEO,
CombiMatrix Corporation (949) 753-0624
Investor Relations Contact:LHAJody Cain(310)
691-7100jcain@lhai.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Combimatrix Corp. (MM) (NASDAQ): 0 recent articles
More News Articles